October 13, 2016

The HDA seminar will host supply chain leaders — including distributors, manufacturers, pharmacists and third-party logistics providers — as well as federal/state regulators.

October 13, 2016

The drug has been approved to treat non-infectious diarrhea in patients with HIV/AIDS on retroviral therapy. 

October 12, 2016

The four-strain influenza vaccine is approved for adults 18 years old and over, and will be available at the beginning of 2017 in pre-filled syringes.

October 12, 2016

The contract will see Merck’s rebates for the drugs based partly on their ability to help Aetna’s commercial members with Type 2 diabetes achieve or maintain treatment goals. 

October 7, 2016

HDA's Perry Fri will continue to serve in his current role as EVP industry relations, membership and education for HDA.

October 6, 2016

With this approval, Orexo now has FDA approval for six dosage strength tablets of the treatment for opioid dependence. 

October 6, 2016
Under the agreement, Lupin would develop multiple pediatric products using Monosol Rx’s PharmFilm drug delivery technology. 
October 4, 2016

As Adapt Pharma’s nasal spray awaited Canadian approval, Canada’s health minister signed an interim order allowing for Food and Drug Administration-approved Narcan nasal spray from Adapt to be sold in Canada.

October 4, 2016

The influenza campaign aims to support the public health effort for flu prevention by making the flu shot available in more than 300 stores in the Jean Coutu network.

October 3, 2016

The new formulation offers a once-daily dosing option that the company says may help some patients achieve and maintain weight loss. 

September 29, 2016

As many as 45.6% of Amerians over the age of six months got their flu shot. Coverage of 46% among the public means about 144 million people received a flu vaccine last season in the U.S.

September 29, 2016

Prime said there were 20.5 million opioid claims in the time period between Jan. 1, 2014 and March 31, 2016. 

September 26, 2016

Janssen Biotech announced Monday that the Food and Drug Administration had approved its Stelara (ustekinumab) to treat moderately to severely active Crohn’s disease.  

September 26, 2016

Pfizer announced Monday that its board of directors and executive leadership team had decided not to split the company into two separate companies, Pfizer Innovative Health and Pfizer Essential Health. The two will remain separately managed units within Pfizer. 

September 23, 2016

The company announced Tuesday that its board of directors had named Paul Campanelli to the position, effective immediately, succeeding Ravid De Silva, who has stepped down from the position and his place on the company's board of directors. 

September 22, 2016
Namzaric is a fixed-dose combination of memantine and 10 mg donepezil hydrochloride indicated to treat moderate to severe Alzheimer’s disease in patients stabilized on 10 mg of donepezil hydrochloride.
September 21, 2016

Invokamet XR is Janssen’s once-daily, extended-release combination therapy of Invokana (canagliflozin) and metformin, the company announced Wednesday.

September 21, 2016

The Pharmaceutical Research and Manufacturers of America (PhRMA) on Wednesday brought 60 of its member companies’ researchers to Capitol Hill for meetings with members of Congress.

September 21, 2016

ATLANTA - The total economic burden attributed to opioid abuse exceeds $78 billion, according to a recent report published in Medical Daily. "More than 40 Americans die each day from overdoses involving prescription opioids. Families and communities continue to be devastated by the epidemic of prescription opioid overdoses." Tom Frieden, director Centers for Disease Control Director shared with Medical Daily. "The rising cost of the epidemic is also a tremendous burden for the health care system." (Medical Daily)

September 20, 2016

Drug maker KVK Tech said its Lomaira is aimed at providing an affordable medicine to aid in weight reduction, with a patient access program that lowers the cost for qualifying patients to no more than $0.50 per tablet during treatment. 

September 20, 2016

GSK's CEO Designate joined GSK in 2010 from L’Oréal where, over the course of her 17-year career, she held a variety of marketing and general management roles in the United Kingdom, Europe and the United States.

September 15, 2016

Currently, the drug comes with a boxed warning regarding serious neuropsychiatric adverse events, and the recommendation to remove it comes after the completion of an Evaluating Adverse Events in Global Smoking Cessation Study (EAGLES) evaluating its safety.

September 14, 2016
Allergan said that, pending approvals, it expects the transaction to close by the end of 2016. 
September 14, 2016
Cuvitru is able to infuse up to 60 mL per site and 60 mL per hour, per site as tolerated, which Shire said results in fewer infusion sites and shorter infusion durations.